Title : Systemic and CNS activity of the RET inhibitor vandetanib combined with the mTOR inhibitor everolimus in KIF5B-RET re-arranged non-small cell lung cancer with brain metastases.

Pub. Date : 2015 Jul

PMID : 25982012






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A co-administration strategy to enhance the brain accumulation of vandetanib by modulating P-gp/Abcb1- and Bcrp1/Abcg2-mediated efflux with mTOR inhibitors, specifically everolimus, was shown to increase the blood-brain barrier penetration. vandetanib mechanistic target of rapamycin kinase Homo sapiens